Results 231 to 240 of about 1,095,380 (327)
Complete response of somatic <i>POLE</i>-ultramutated recurrent undifferentiated uterine sarcoma to pembrolizumab and concurrent radiotherapy. [PDF]
Charewycz NE+6 more
europepmc +1 more source
Understanding miR‐200c: an Important Player in Resistance to Cancer Treatment
How can one microRNA alter cancer's response to therapy? miR‐200c plays a central role in therapeutic resistance by modulating epithelial‐mesenchymal transition, apoptosis, cancer stemness features, and drug efflux. This review outlines the context‐dependent functions of miR‐200c in various cancers and highlights its potential as both a biomarker and a
Fatma Sanli, Omer Faruk Karatas
wiley +1 more source
A Case of Colon Leiomyosarcoma Arising from the Muscularis Mucosae: A Case Report and Literature Review. [PDF]
Kasagi Y+10 more
europepmc +1 more source
Cancer cell‐intrinsic SMYD3 orchestrates an immunosuppressive microenvironment and impairs the response to PD‐1 blockade by reprogramming immune cells landscape in the tumor microenvironment of clear cell renal cell carcinoma (ccRCC). The immunomodulatory function of SMYD3 is mediated via the SREBP1/CD47 pathway.
Zhengfang Liu+14 more
wiley +1 more source
Malignant Struma Ovarii: A Rare Manifestation of Ectopic Thyroid Cancer. [PDF]
Morley A, Koh CK, Gonzalez M.
europepmc +1 more source
Extracellular matrix remodeling is crucial in cancer progression. Using a peptide to probe the tension of ECM fibers, it was found that Fibronectin fibers gradually lose tension as human breast carcinoma progresses, while their tension is maintained in ductal carcinoma in situ (DCIS), the non‐invasive precursor of breast cancer. This loss of tension is
Arnaud Miéville+6 more
wiley +1 more source
Malignant retroperitoneal schwannoma in a young adult: rapid recurrence, metastasis, and treatment reflections-a case report. [PDF]
Zhao Z, Fan S, Yu D, Wang G.
europepmc +1 more source
Does Surgical Margin Impact Recurrence in Noninvasive Intraductal Papillary Mucinous Neoplasms?
Vikrom K. Dhar+20 more
openalex +2 more sources
Midkine (MDK) is a mediator of the interaction between pancreatic cancer and beta cells. MDK, which originated from pancreatic ductal adenocarcinoma cells, exerted deleterious effects on paraneoplastic beta cells by binding to the SDC4 receptor on the beta cell surface and subsequently downregulating the Ras signaling pathway, thereby impairing insulin
Zengyu Feng+7 more
wiley +1 more source